A carregar...
Publicação
Variation in communication and family visiting policies in intensive care within and between countries during the Covid-19 pandemic
| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 886.67 KB | Adobe PDF |
Autores
Orientador(es)
Resumo(s)
Background: During the COVID-19 pandemic, intensive care units (ICU) introduced restrictions to in-person family visiting to safeguard patients, healthcare personnel, and visitors. Methods: We conducted a web-based survey (March–July 2021) investigating ICU visiting practices before the pandemic, at peak COVID-19 ICU admissions, and at the time of survey response. We sought data on visiting policies and communication modes including use of virtual visiting (videoconferencing). Results: We obtained 667 valid responses representing ICUs in all continents. Before the pandemic, 20% (106/525) had unrestricted visiting hours; 6% (30/525) did not allow in-person visiting. At peak, 84% (558/667) did not allow in-person visiting for patients with COVID-19; 66% for patients without COVID-19. This proportion had decreased to 55% (369/667) at time of survey reporting. A government mandate to restrict hospital visiting was reported by 53% (354/646). Most ICUs (55%, 353/615) used regular telephone updates; 50% (306/667) used telephone for formal meetings and discussions regarding prognosis or end-of-life. Virtual visiting was available in 63% (418/667) at time of survey. Conclusions: Highly restrictive visiting policies were introduced at the initial pandemic peaks, were subsequently liberalized, but without returning to pre-pandemic practices. Telephone became the primary communication mode in most ICUs, supplemented with virtual visits.
Descrição
Funding Information: This project was conducted without funding. Guy Francois is an employee of the European Society of Intensive Care Medicine (ESICM) and as such his time working on the project and access to SurveyMonkey platform was supported by ESICM.Alexis Tabah has nothing to disclose, Muhammed Elhadi has nothing to disclose, Emma Ballard has nothing to disclose, Andrea Cortegiani has nothing to disclose, Maurizio Cecconi reports personal fees from Edwards Lifesciences, Directed Systems, Takeshi Unoki has nothing to disclose, Laurą Galarza has nothing to disclose, Regis Goulart Rosa has received research grants from the Brazilian Ministry of Health to conduct studies on the topic of ICU visiting policies, Francois Barbier reported consulting and lecture fees, conference invitation from MSD and lecture fees from BioMérieux, Elie Azoulay reports receiving fees for lectures from Gilead, Pfizer, Baxter, and Alexion. His research group has been supported by Ablynx, Fisher & Payckle, Jazz Pharma, and MSD, outside the submitted work, Kevin B Laupland has nothing to disclose, Nathalie Ssi Yan Kai has nothing to disclose, Marlies Ostermann has nothing to disclose, Guy Francois has nothing to disclose, Jan J De Waele reports grants from Research Foundation Flanders, during the conduct of the study; other from Pfizer, other from MSD, outside the submitted work, Kirsten Fiest has nothing to disclose, Peter Spronk has nothing to disclose, Julie Benbenishty has nothing to disclose, Mariangela Pellegrini has nothing to disclose, Louise Rose is a co-founder of Life Lines, a philanthropic COVID-19 rapid response project that received charitable donations to enable provision of 4G enabled Android tablets and a bespoke virtual visiting solution to ICUs across the UK. LR has no financial or commercial interests in Life Lines or the virtual visiting solution. Major philanthropic contributors to Life Lines include Google, True Colours and the Gatsby Trust. British Telecom contributed in-kind time and resources to facilitate the supply of 4G enabled tablets to UK ICUs. Funding Information: Alexis Tabah has nothing to disclose, Muhammed Elhadi has nothing to disclose, Emma Ballard has nothing to disclose, Andrea Cortegiani has nothing to disclose, Maurizio Cecconi reports personal fees from Edwards Lifesciences, Directed Systems, Takeshi Unoki has nothing to disclose, Laurą Galarza has nothing to disclose, Regis Goulart Rosa has received research grants from the Brazilian Ministry of Health to conduct studies on the topic of ICU visiting policies, Francois Barbier reported consulting and lecture fees, conference invitation from MSD and lecture fees from BioMérieux, Elie Azoulay reports receiving fees for lectures from Gilead, Pfizer, Baxter, and Alexion. His research group has been supported by Ablynx , Fisher & Payckle, Jazz Pharma, and MSD, outside the submitted work, Kevin B Laupland has nothing to disclose, Nathalie Ssi Yan Kai has nothing to disclose, Marlies Ostermann has nothing to disclose, Guy Francois has nothing to disclose, Jan J De Waele reports grants from Research Foundation Flanders, during the conduct of the study; other from Pfizer, other from MSD, outside the submitted work, Kirsten Fiest has nothing to disclose, Peter Spronk has nothing to disclose, Julie Benbenishty has nothing to disclose, Mariangela Pellegrini has nothing to disclose, Louise Rose is a co-founder of Life Lines, a philanthropic COVID-19 rapid response project that received charitable donations to enable provision of 4G enabled Android tablets and a bespoke virtual visiting solution to ICUs across the UK. LR has no financial or commercial interests in Life Lines or the virtual visiting solution. Major philanthropic contributors to Life Lines include Google, True Colours and the Gatsby Trust. British Telecom contributed in-kind time and resources to facilitate the supply of 4G enabled tablets to UK ICUs. Publisher Copyright: © 2022 Elsevier Inc.
Palavras-chave
COVID-19 Family Intensive care Restriction Visiting Critical Care and Intensive Care Medicine